Review
Published on 16 Dec 2022
Targeted alpha therapy for glioblastoma
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1085245
- 7,987 views
- 21 citations
16 articles related to "Alpha Therapy"
Articles
Mini Review
Published on 27 Jul 2021
Revisiting the Radiobiology of Targeted Alpha Therapy
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2021.692436
- 25,739 views
- 129 citations
Review
Published on 22 Dec 2022
Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand?
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1020188
- 21,671 views
- 54 citations
Original Research
Published on 10 Oct 2022
Intraperitoneal alpha therapy with 224Ra-labeled microparticles combined with chemotherapy in an ovarian cancer mouse model
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.995325
- 5,032 views
- 5 citations
Review
Published on 14 Jan 2014
The Potential and Hurdles of Targeted Alpha Therapy – Clinical Trials and Beyond
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2013.00324
- 32,052 views
- 183 citations
Review
Published on 06 Jan 2023
Astatine-211 based radionuclide therapy: Current clinical trial landscape
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1076210
- 30,350 views
- 79 citations
Hypothesis and Theory
Published on 17 Jan 2023
Dual targeting with 224Ra/212Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1051825
- 7,477 views
- 12 citations
Original Research
Published on 23 Nov 2022
Targeted alpha therapy with the 224Ra/212Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1058863
- 5,202 views
- 11 citations
Review
Published on 07 Aug 2025
Targeted radionuclide therapy and diagnostic imaging of SSTR positive neuroendocrine tumors: a clinical update in the new decade
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2025.1655419
- 6,324 views
- 1 citation
Mini Review
Published on 09 Jan 2023
Targeted thorium-227 conjugates as treatment options in oncology
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1071086
- 9,837 views
- 31 citations
Original Research
Published on 15 Nov 2022
Tumor growth inhibition and immune system activation following treatment with thorium-227 conjugates and PD-1 check-point inhibition in the MC-38 murine model
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1033303
- 4,725 views
- 9 citations
Brief Research Report
Published on 08 Aug 2024
Concept validation of separations for thorium-based radionuclide generator systems for medical application
in Nuclear Materials
Frontiers in Nuclear Engineering
doi 10.3389/fnuen.2024.1379996
- 3,184 views
Original Research
Published on 05 Nov 2020
Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of 225Ac-PSMA (Prostate-Specific Membrane Antigen)
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.531660
- 9,372 views
- 29 citations
Systematic Review
Published on 03 Feb 2022
Efficacy and Safety of 225Ac-PSMA-617-Targeted Alpha Therapy in Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.796657
- 23,276 views
- 73 citations
Original Research
Published on 25 Jan 2024
Pb-214/Bi-214-TCMC-Trastuzumab inhibited growth of ovarian cancer in preclinical mouse models
in Medicinal and Pharmaceutical Chemistry
Frontiers in Chemistry
doi 10.3389/fchem.2023.1322773
- 6,905 views
- 7 citations
Original Research
Published on 28 Feb 2022
Vaccination for SARS-CoV-2 in Patients With Psoriatic Arthritis: Can Therapy Affect the Immunological Response?
in Dermatology
Frontiers in Medicine
doi 10.3389/fmed.2022.811829
- 4,735 views
- 13 citations